Precise Phenotyping and Treatment

14 Apr 2024 9 a.m. 10:30 a.m.
Hall C4
HeatherReich Chairperson University of Toronto, University Health NetworkCanada
SebastiánJaurretche Chairperson Sanatorio Parque SAArgentina

Session Description :
This session is designed to teach the audience concerning newer approaches for the diagnosis and sub-phenotyping of kidney diseases and the latest developments in therapy. 
Learning Objectives:
Understand the challenges and opportunities for diagnosing and treating rare diseases in developing countries. Review the latest developments in targeting the complement pathway for treatment of kidney disease. Understand how the revolution in CAR-T therapies is affecting the treatment of refractory lupus nephritis. 

Time Session
9 a.m.
9:18 a.m.
Deciphering the IGAN Cell Atlas
JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany
9:18 a.m.
9:36 a.m.
Complement-mediated Kidney Diseases in the Era of Complement Inhibitors
MarinaVivarelli Speaker marina.vivarelli@opbg.netLaboratory of Nephrology, Bambino Gesù Children's HospitalItaly
9:36 a.m.
9:54 a.m.
CART-T
JonathanHogan Speaker jonathan.hogan@cabalettabio.comCabaletta Bio
9:54 a.m.
10:15 a.m.
New Targets to Reduce the Burden of Rare Kidney Diseases
LauraMariani Speaker University of MichiganUnited States
10:15 a.m.
10:30 a.m.
Q and A